Intapp enters the post-earnings period with a stock that has fallen hard and shorts that are still elevated despite a partial unwind — a combination that makes the current setup genuinely worth watching.
The most striking feature of INTA's positioning right now is that short interest, while easing, remains near a 30-day high. SI sits at roughly 8.7% of the free float after peaking above 9.4% in the days immediately following the May 5 earnings release. That post-print short build was dramatic — borrowing jumped by nearly 56% relative to late-April levels, when SI was running around 6.1%. The partial retreat this week, down about 7% over seven days to 4.5 million shares short, looks like profit-taking after the initial bearish move rather than a genuine reversal of sentiment. With 7 days to cover per the latest FINRA data, the position is not trivially quick to unwind. Borrow remains easy at 0.46% — no cost pressure deterring fresh shorts — and availability, while not extreme, is well within normal range, so the lending market is not yet providing the friction that often precedes short covering.
Options pricing has shifted markedly defensive in the same window. The put/call ratio has climbed to 0.73, its highest reading of the past year, against a 20-day average of 0.53. That puts the z-score at 1.5 — not a full two-sigma extreme, but a clear directional lean toward downside protection that tracks with the stock's slide. INTA fell 5.4% on the week to $22.77 and is down 4.4% on Tuesday alone. The options market and the short book are, for once, telling the same story: investors are more cautious about INTA right now than at almost any point in the past year.
The Street's reaction to the Q3 report was mixed — and the divergence in analyst target moves captures the tension well. JP Morgan maintained its Overweight rating but cut the target from $58 to $47, a 19% reduction that keeps the bull case alive while acknowledging the stock's reset lower. Citigroup moved in the other direction on the multiple, lifting its Neutral target from $26 to $29, apparently reassured by the print even if not yet prepared to turn positive. Barclays, which has been bearish all year, raised its Underweight target from $20 to $25. The consensus mean of $34.57 implies more than 50% upside from the current price of $22.77 — but that mean is being dragged upward by bullish outliers; the analyst_rec_diff factor scores in the 99th percentile, a reflection of the widening gap between where analysts have targets and where the stock is trading. Bulls point to Intapp's agentic AI platform Celeste, a $1 billion ARR target for FY29, and deepening penetration across professional services. Bears counter that the path to profitability stretches to FY28 at the earliest, and that niche positioning in legal, advisory, and financial services limits the addressable market ceiling.
One institutional angle worth noting: FMR (Fidelity) added nearly 960,000 shares in the latest reporting period, making it the most aggressive incremental buyer among top holders. BlackRock added around 155,000. Against that, Luxor Capital trimmed its position by approximately 197,000 shares at year-end 2025. Temasek Holdings, with 22% of shares, sits largely unmoved. No recent open-market insider buying is visible in the data — the February transactions were primarily equity awards and a CEO stock sale at $22.16, almost exactly where the stock trades now.
The next material datapoint is a re-read of whether the short book continues to normalise below the 9% peak or reasserts above it. INTA's closest peers are under pressure too — HUBS fell 27% on the week after its own report, and TEAM dropped nearly 8% — so the sector bid is not currently providing a tailwind. Watch whether the put/call ratio re-anchors closer to its 0.53 mean, or stays elevated near the 0.73–0.74 range it has occupied since May 5: that will indicate whether options traders view the post-earnings selloff as done or still developing.
See the live data behind this article on ORTEX.
Open INTA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
